Global pharmas have taken interest in the region following improvements in the regulatory environment, rising incomes, skilled workforces and opportunities for contract manufacturing.
Market Size in 2011: $18.2 billion
Population: 464 million combined
Industry Makeup: GlaxoSmithKline, Pfizer, Sanofi-Aventis, Ranbaxy Laboratories and Takeda Pharmaceutical are active in the region.
Branded vs. Generic: Vietnam has a strong generic market (90 percent of the total), while Singapore's market is 20 percent of the total. The over-the-counter sector is expanding throughout the region.
Distribution: Large distributors include Zuellig Pharma
Main Customers: Varies among countries
Estimated growth by 2015: 7 to 10 percent
Sources: IMS Health, PharmaVentures, RNCOS